Shares of EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) got a boost, shooting up 19 percent to $0.713 after the company reported the FDA approval of two Investigational Device Exemption applications for the company’s Ocular Bandage Gel.

Bridgeline Digital, Inc. (NASDAQ: BLIN) shares were also up, gaining 25 percent to $1.87 as the company disclosed that a global engine manufacturer launched a UK B2C eCommerce website on Bridgeline's Unbound Platform.